Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
Sponsor: Eledon Pharmaceuticals
Summary
This study will evaluate the long term safety and efficacy of AT-1501 (tegoprubart) compared with tacrolimus in patients undergoing kidney transplantation.
Official title: AT-1501-K209: BESTOW-EXTENSION: A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
132
Start Date
2023-10-25
Completion Date
2029-12
Last Updated
2025-12-10
Healthy Volunteers
No
Conditions
Interventions
AT-1501
AT-1501 20 mg/kg administered every 3 weeks IV + MMF 1000 mg PO twice daily (BID) or MPS 720 mg PO BID + Corticosteroids 5 mg of prednisone PO once daily (QD) or equivalent
Tacrolimus
Tacrolimus dosed PO BID with the dose titrated to maintain a trough concentration of 6-8 ng/mL+ MMF 1000 mg PO BID or MPS 720 mg PO BID + Corticosteroids 5 mg of prednisone PO QD or equivalent
Locations (43)
University of California Los Angeles
Los Angeles, California, United States
Keck School of Medicine of USC
Los Angeles, California, United States
University of California, Irvine Medical Center
Orange, California, United States
University of California, Davis Medical Center
Sacramento, California, United States
Jacobs Medical Center at UC San Diego Health
San Diego, California, United States
MedStar Georgetown University Hospital
Washington D.C., District of Columbia, United States
Tampa General Hospital
Tampa, Florida, United States
Emory University Hospital
Atlanta, Georgia, United States
Augusta University
Augusta, Georgia, United States
University of Chicago
Chicago, Illinois, United States
Loyola University Medical Center
Maywood, Illinois, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Tulane Medical Center
New Orleans, Louisiana, United States
John Hopkins University
Baltimore, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Henry Ford Health System
Detroit, Michigan, United States
University of Minnesota Medical Center
Minneapolis, Minnesota, United States
Mayo Clinic
Rochester, Minnesota, United States
Washington University in St. Louis
St Louis, Missouri, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
New York University Langone Health - Tisch Hospital
New York, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
University of Cincinnati Medical Center
Cincinnati, Ohio, United States
University of Pittsburgh Medical Center
Harrisburg, Pennsylvania, United States
UT Southwestern
Dallas, Texas, United States
Virginia Commonwealth University
Richmond, Virginia, United States
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Fiona Stanley Hospital
Perth, Western Australia, Australia
Fundação Oswaldo Ramos - Hospital do Rim
São Paulo, Brazil
Hospital das Clínicas da Faculdade de Medicina de São Paulo
São Paulo, Brazil
St. Paul's Hospital
Vancouver, British Columbia, Canada
McGill University Health Care Centre
Montreal, Quebec, Canada
Groupe Hospitalier Pellegrin
Bordeaux, France
CHU Grenoble-Alpes - Hopital Nord Michallon
Grenoble, France
Centre Hospitalier Universitaire Dupuytren
Limoges, France
CHU de Toulouse - Hopital de Rangueil
Toulouse, France
Charite Universitatsmedizin Berlin
Berlin, Germany
Hospital del Mar - Parc de Salut Mar
Barcelona, Spain
Hospital Universitari Vall d'Hebron
Barcelona, Spain
Hospital Clinical de Barcelona
Barcelona, Spain
Hospital Universitari de Bellvitge
Barcelona, Spain
Hospital Germans Trias i Pujol
Barcelona, Spain
Oxford University Hospitals NHS Foundation Trust - John Radcliffe Hospital
Oxford, United Kingdom